Cargando…
Anti-drug resistance, anti-inflammation, and anti-proliferation activities mediated by melatonin in doxorubicin-resistant hepatocellular carcinoma: in vitro investigations
Hepatocellular carcinoma (HCC) is the major life-threatening primary liver malignancy in both sexes all over the world. Unfortunately, the majority of patients are diagnosed at later stages because HCC does not elicit obvious symptoms during its early incidence. Consequently, most individuals escape...
Autores principales: | Hamed, Ahmed R., Yahya, Shaymaa M. M., Nabih, Heba K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185645/ https://www.ncbi.nlm.nih.gov/pubmed/36651944 http://dx.doi.org/10.1007/s00210-023-02385-w |
Ejemplares similares
-
Anti-proliferative effect of melatonin in human hepatoma HepG2 cells occurs mainly through cell cycle arrest and inflammation inhibition
por: Nabih, Heba K., et al.
Publicado: (2023) -
Melatonin: an anti-tumor agent for osteosarcoma
por: Fathizadeh, Hadis, et al.
Publicado: (2019) -
The Impact of Melatonin on Colon Cancer Cells’ Resistance to Doxorubicin in an In Vitro Study
por: Fic, Magdalena, et al.
Publicado: (2017) -
In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.
por: Ripamonti, M., et al.
Publicado: (1992) -
Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment
por: Licarete, Emilia, et al.
Publicado: (2020)